CPR Pharma Services Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:N/A
Industry:Pharma
Founded:1996
Lead Investor(s):N/A

Estimated Revenue & Financials

  • CPR Pharma Services's estimated annual revenue is currently $23.5M per year.(?)
  • CPR Pharma Services's estimated revenue per employee is $201,000

Employee Data

  • CPR Pharma Services has 117 Employees.(?)
  • CPR Pharma Services grew their employee count by 13% last year.
  • CPR Pharma Services currently has 1 job openings.

CPR Pharma Services has developed a solid reputation for delivering clinical studies; on time and on budget. Our professional customer service and the speed and quality of our work sets us apart from our competitors; which is why we enjoy an 85% rate of repeat business from satisfied sponsors. We are the only Australian CRO to offer a full suite of in-house services including clinical project management and monitoring, data services, pharmacokinetics, statistics and report writing through to bio-analytical services including ground-breaking work in biomarker and peptide studies. Our Fast2PhaseOne service enables clients to make a fast Go / No Go decision for their first-in-human trials thanks to Australia's regulatory advantages including: o streamlined Clinical Trials Notification (CTN) Scheme o full Good Manufacturing Practice (GMP) material not required o no Investigational New Drug (IND) application required Together with our assistance to foreign clients interested in gaining access to the Australian R&D Tax Incentive (including current US-based clients), CPRs offering is unique in the industry and strengthens its international competitiveness while providing a cost-effective alternative to contract research organisations in Europe and the US. Headquartered in South Australia, CPR Pharma Services operates within a stringent ICH GCP / GLP environment overseen by our internationally recognised scientific staff and has been inspected by both the FDA and EMA. For more information, visit www.cprpharma.com.

keywords:N/A